We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

31 hedge funds and large institutions have $55.7M invested in Cipher Pharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

19% more funds holding

Funds holding: 2631 (+5)

7% more capital invested

Capital invested by funds: $51.8M → $55.7M (+$3.85M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
31
Holders Change
+5
Holders Change %
+19.23%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
13
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Prelude Capital Management
New York
$34K +$22.9K +1,820 +97%
Citigroup
27
Citigroup
New York
$18K -$10.9K -869 -31%
TRCT
28
Tower Research Capital (TRC)
New York
$14K +$12.9K +1,025 +201%
Wells Fargo
29
Wells Fargo
California
$9K
UBS Group
30
UBS Group
Switzerland
$6K +$8.93K +711 New
Toronto Dominion Bank
31
Toronto Dominion Bank
Ontario, Canada
$1K +$892 +71 New
HIM
32
Hillsdale Investment Management
Ontario, Canada
-$1.15M -79,440 Closed
CIBC World Market
33
CIBC World Market
Ontario, Canada
-$165K -11,656 Closed
CSS
34
Cubist Systematic Strategies
Connecticut
-$151K -10,500 Closed

CPHR Hedge Fund Activity: Q1 2015 in Review

31 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q1 2015, worth a combined $55.7M — up 7.4% from $51.8M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CPHR positions and 3 closed out — a net gain of 5 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was Montrusco Bolton Investments, opening a new position worth an estimated $17.6M. The largest seller was Raffles Associates, cutting an estimated $1.16M.

  • 31 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q1 2015, up from 26 in Q4 2014.
  • Funds reported $55.7M of Cipher Pharmaceuticals Inc. stock for Q1 2015, up 7.4% quarter-over-quarter.
  • 8 funds opened new Cipher Pharmaceuticals Inc. positions in Q1 2015 and 3 closed out, a net change of +5 holders.
  • The largest Cipher Pharmaceuticals Inc. buyer in Q1 2015 was Montrusco Bolton Investments, an estimated $17.6M added.
  • The largest Cipher Pharmaceuticals Inc. seller in Q1 2015 was Raffles Associates, an estimated $1.16M sold.

Based on aggregated 13F filings for Q1 2015.